Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
about
Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathyVascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathyCrosstalk in glomerular injury and repairAntiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetesAcute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control studySemaphorin3a promotes advanced diabetic nephropathyVascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytesDelayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal InjuryTwenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice.Vegfa protects the glomerular microvasculature in diabetes.Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Podocytes: the Weakest Link in Diabetic Kidney Disease?Elevated expression levels of serum insulin-like growth factor-1, tumor necrosis factor-α and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy.New insights into molecular mechanisms of diabetic kidney disease.Semaphorin3a signaling, podocyte shape, and glomerular disease.Semaphorins in kidney development and disease: modulators of ureteric bud branching, vascular morphogenesis, and podocyte-endothelial crosstalk.VEGF and podocytes in diabetic nephropathy.Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytesTherapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.Vitamin D and its receptor regulate lipopolysaccharide-induced transforming growth factor-β, angiotensinogen expression and podocytes apoptosis through the nuclear factor-κB pathwayAntiangiogenic Therapy for Diabetic Nephropathy.Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.The vasculature in diabetic nephropathy: all tied up?Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach
P2860
Q24338974-F4916F05-80C8-4DFB-89D8-7D7D5E64A77DQ27342809-DAE0CF5F-80C6-46C8-8A24-BBFBA933A872Q28085092-E770750C-BA16-4FA1-B73B-3E7C1B9C909BQ28538183-203AC801-4A62-4E7C-BDB8-CA5B9BC5856BQ31074551-4B4B6E2E-ED85-446C-857E-9ED13A5F3B37Q33974608-9CA4553D-6F45-4723-98C2-29B75B2E4239Q34395293-702AC9CF-CE4F-46E8-BEC8-E2DAE94CE708Q35532272-89321734-1701-40B3-B143-226ACA0E677CQ35562791-EB8B1ADA-CBC5-4933-976C-43951D1C6077Q35710293-D38FC2CB-E6A0-41AB-A34C-7E88E4EF9F93Q36297539-DEDE0A39-B46C-478F-82F5-28B219EF0CFDQ36312650-4A89C872-A5CD-4A0A-BEB5-792A1B03C4D3Q36339615-C6230014-F018-4A34-BF71-25BE97CA829EQ37142636-363EDCA2-AAE8-4EC1-8C33-112C96C90494Q37340690-F65956A2-A855-4F82-9E6D-D4AF1B64E450Q37567736-FB0D63DB-E2BB-40CB-AF22-2D7BB723E28FQ37598306-7E96E0D6-08F0-4D58-8081-6FCAAEDA07B2Q37711201-70039864-A44D-47A1-A77C-C8BA0A4345E9Q37845241-A4AAEDED-3E63-4039-8E8F-F49ACBA3D3F9Q38041671-F36D5964-FBEC-4FE3-891B-54521DA70D11Q38332511-82E2B230-D89D-403D-9C45-A9B069440FECQ38883369-847E88A1-C61F-48AF-873F-749622E37C2AQ41001885-55C1D278-36EF-4A7E-980A-E58652DD6666Q41403094-AE9F9526-C2E2-4E03-9B4A-908409FE7CD9Q41884505-8FDEB753-3F8A-47A4-80AF-35EFE62B582FQ42778043-AADD4F49-8B5A-4DFC-948C-F6B34898E7CFQ42778066-8CDC7D38-9122-4881-9859-AF771245F459Q45072634-F0162BE3-F0F2-486A-984E-D530A6E98495Q52593829-2A04900F-81EF-4486-A961-E00058B9562EQ57652246-70AE35B5-E231-4FD6-89E5-632939C9B13C
P2860
Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Podocyte vascular endothelial ...... ouse model of type 1 diabetes.
@en
type
label
Podocyte vascular endothelial ...... ouse model of type 1 diabetes.
@en
prefLabel
Podocyte vascular endothelial ...... ouse model of type 1 diabetes.
@en
P2093
P2860
P921
P1433
P1476
Podocyte vascular endothelial ...... mouse model of type 1 diabetes
@en
P2093
A M Garcia
C A Bertuccio
H Velazquez
M Kashgarian
P2860
P2888
P304
P356
10.1007/S00125-010-2034-Z
P577
2011-02-12T00:00:00Z